Linepharma

Japan’s drug regulatory system experienced several changes designed to open up the market and encourage the development of novel products, and the positive shift seems set to continue in 2024. However

Japan has finally approved mifepristone as a new option for medical abortion, amid rising demand from the public for the oral drug and a desire to properly regulate its use. While a legal battle in th

Five big investments in health care and life science funds since the end of October delivered more than $1bn in new financing for companies developing biopharmaceuticals and related technology. The ne

AcelRx Pharmaceuticals Inc. ’s bid to bring its acute pain treatment Zalviso to the U.S. market has been tripped up by issues with the device for the sufentanil sublingual tablet system. FDA has is